Improvement of [beta]-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control
Background Achieving euglycaemia by continuous subcutaneous insulin infusion (CSII) therapy alone has been shown to restore [beta]-cell function in patients with newly diagnosed type 2 diabetes. However, the efficacy has not been evaluated in patients with non-newly diagnosed type 2 diabetes and sub...
Gespeichert in:
Veröffentlicht in: | Diabetes/metabolism research and reviews 2013-09, Vol.29 (6), p.473 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!